 |
|
Cognitive problems associated with diabetes duration and severity
August 12, 2008Individuals with mild cognitive impairment appear more likely to have earlier onset, longer duration and greater severity of diabetes, according to a report in the August issue of Archives of Neurology, one of the JAMA/Archives journals.
Mild cognitive impairment is a transitional stage between normal aging and dementia, according to background information in the article. Previous studies have found an association between mild cognitive impairment and diabetes. Poor blood glucose control over time may lead to neuron loss, and diabetes is associated with cardiovascular disease risk and stroke, which also may increase the risk of cognitive impairment.
Rosebud O. Roberts, M.B.Ch.B., M.S., and colleagues at Mayo Clinic, Rochester, Minn., studied individuals from Olmsted County, Minnesota, who were age 70 to 89 on Oct. 1, 2004. Participants received a neurological examination, neuropsychological evaluation and tests of blood glucose levels, and completed an interview with questions about diabetes history, treatment and complications. A medical records linkage system was used to confirm diabetes history.
Rates of diabetes were similar among 329 individuals with mild cognitive impairment (20.1 percent) and 1,640 participants without mild cognitive impairment (17.7 percent). However, mild cognitive impairment was associated with developing diabetes before age 65, having diabetes for 10 years or longer, being treated with insulin and having diabetes complications.
"Severe diabetes mellitus is more likely to be associated with chronic hyperglycemia [high blood glucose], which, in turn, increases the likelihood of cerebral microvascular disease and may contribute to neuronal damage, brain atrophy and cognitive impairment," the authors write. That individuals with the eye disease diabetic retinopathy were twice as likely to have mild cognitive impairment supports the theory that diabetes-related damage to blood vessels in the brain may contribute to the development of cognitive problems.
"Our findings suggest that diabetes mellitus duration and severity, as measured by type of treatment and the presence of diabetes mellitus complications, may be important in the pathogenesis of cognitive impairment in subjects with diabetes mellitus," they conclude. "In contrast, late onset of diabetes mellitus, short duration of diabetes mellitus or well-controlled diabetes mellitus may have a lesser effect."
JAMA and Archives Journals
Rates of diabetes were similar among 329 individuals with mild cognitive impairment (20.1 percent) and 1,640 participants without mild cognitive impairment (17.7 percent). However, mild cognitive impairment was associated with developing diabetes before age 65, having diabetes for 10 years or longer, being treated with insulin and having diabetes complications.
"Severe diabetes mellitus is more likely to be associated with chronic hyperglycemia [high blood glucose], which, in turn, increases the likelihood of cerebral microvascular disease and may contribute to neuronal damage, brain atrophy and cognitive impairment," the authors write. That individuals with the eye disease diabetic retinopathy were twice as likely to have mild cognitive impairment supports the theory that diabetes-related damage to blood vessels in the brain may contribute to the development of cognitive problems.
"Our findings suggest that diabetes mellitus duration and severity, as measured by type of treatment and the presence of diabetes mellitus complications, may be important in the pathogenesis of cognitive impairment in subjects with diabetes mellitus," they conclude. "In contrast, late onset of diabetes mellitus, short duration of diabetes mellitus or well-controlled diabetes mellitus may have a lesser effect."
JAMA and Archives Journals
Mild Cognitive Impairment Current Events and Mild Cognitive Impairment News RSSReduced muscle strength associated with risk for Alzheimer's
Individuals with weaker muscles appear to have a higher risk for Alzheimer's disease and declines in cognitive function over time, according to a report in the November issue of Archives of Neurology, one of the JAMA/Archives journals.
Chemobrain - the flip side of surviving cancer
One of the most problematic side effects of cancer treatment, chemobrain - a range of symptoms including memory loss, inability to concentrate, difficulty thinking and other subtle cognitive changes following chemotherapy - seriously diminishes women's quality of life and daily functioning.
High fruit and vegetable intake positively correlated with antioxidant status, cognitive performance
Researchers at the Institute of Biochemistry and Molecular Biology I of the Heinrich-Heine University, Düsseldorf, Germany, investigated the relationship between fruit and vegetable intake, plasma antioxidant micronutrient status and cognitive performance in healthy subjects aged 45 to 102 years.
Vitamin D, curcumin may help clear amyloid plaques found in Alzheimer's disease
UCLA scientists and colleagues from UC Riverside and the Human BioMolecular Research Institute have found that a form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta, which forms the plaques considered the hallmark of Alzheimer's disease.
Phase 3 Alzheimer's drug increases toxic beta amyloid in the brain -- but still provides benefits
New insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.
Regular moderate alcohol intake has cognitive benefits in older adults
A glass of wine here, a nightcap there - new research out of Wake Forest University School of Medicine suggests that moderate alcohol intake offers long-term cognitive protection and reduces the risk of dementia in older adults.
UCLA scientists identify how immune cells may help predict Alzheimer's risk
What if you could test your risk for Alzheimer's disease much like your cholesterol levels - through a simple blood test?
Brain imaging and proteins in spinal fluid may improve Alzheimer's prediction and diagnosis
Changes in the brain measured with MRI and PET scans, combined with memory tests and detection of risk proteins in body fluids, may lead to earlier and more accurate diagnosis of Alzheimer's.
Memory test and PET scans detect early signs of Alzheimer's
A large study of patients with mild cognitive impairment revealed that results from cognitive tests and brain scans can work as an early warning system for the subsequent development of Alzheimer's disease.
Mayo Clinic study continues to refine most effective methods to predict Alzheimer's disease
A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test.
More Mild Cognitive Impairment Current Events and Mild Cognitive Impairment News Articles
 |
Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis by Jeffrey Burns (Author), John Morris (Author) Written by leading authorities in the field, this book describes the cognitive changes associated with age, the earliest detectable stages of Alzheimer’s, and the relationship of these conditions to MCI. The authors review the latest advances in our understanding of MCI, its prevalence, evaluation, management, and outcomes and in so doing provide practising physicians with a useful resource that assists them in identifying those MCI patients who will progress to recognised Alzheimer’s Disease. Beautifully presented in full colour, Early Diagnosis and Treatment of Mild Cognitive Impairment includes case studies and discusses future therapeutic and diagnostic strategies. It is an invaluable resource for postgraduates and professionals, for specialist physicians in neurology... |
 |
Mild Cognitive Impairment: Aging to Alzheimer's Disease (Medicine) by Ronald C. Petersen (Editor) What are the boundary zones between normal aging and Alzheimer's disease (AD)? Are many elderly people whom we regard as normal actually in the early stages of AD? Alzheimer's disease does not develop overnight; the early phases may last for years or even decades. Recently, clinical investigators have identified a transitional condition between normal aging and and very early Alzheimer's disease that they have called mild cognitive impairment, or MCI. This term typically refers to memory impairment beyond what one would expect in individuals of a given age whose other abilities to function in daily life are well preserved. Persons who meet the criteria for mild cognitive impairment have an increased risk of progressing to Alzheimer's disease in the near future. Though many questions... |
 |
Perspectives on Mild Cognitive Impairment (Studies on Neuropsychology, Neurology and Cognition) by Holly A. Tuokko (Author), David F. Hultsch (Author) Mild Cognitive Impairment (MCI) has been identified as an important clinical transition between normal aging and the early stages of Alzheimer's disease (AD). Since treatments for AD are most likely to be most effective early in the course of the disease, MCI has become a topic of great importance and has been investigated in different populations of interest in many countries. This book brings together these differing perspectives on MCI for the first time. |
|
Dysgraphia in Alzheimer's disease with mild cognitive impairment.: An article from: Journal of Medical Speech - Language Pathology by Sunita Kavrie (Author), Jean Neils-Strunjas (Author) This digital document is an article from Journal of Medical Speech - Language Pathology, published by Delmar Learning on March 1, 2002. The length of the article is 5905 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Dysgraphia in Alzheimer's disease with mild cognitive impairment. Author: Sunita Kavrie Publication: Journal of Medical Speech - Language Pathology (Refereed) Date: March 1, 2002 Publisher: Delmar Learning Volume: 10 Issue: 1 Page: 73(10) Distributed by Thomson... | |
|
SSRIs are associated with mild cognitive impairment. (Watch Geriatric Patients Closely).(selective serotonin reuptake inhibitors)(Brief Article): An article from: Clinical Psychiatry News by Carl Sherman (Author) This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on April 1, 2002. The length of the article is 2767 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: SSRIs are associated with mild cognitive impairment. (Watch Geriatric Patients Closely).(selective serotonin reuptake inhibitors)(Brief Article) Author: Carl Sherman Publication: Clinical Psychiatry News (Magazine/Journal) Date: April 1, 2002 Publisher: International Medical News Group Volume: 30 Issue: 4 Page: 12(1) Article Type: Brief... | |
 |
Predicting conversion to dementia in mild cognitive impairment by [A short communication from: Psychiatry Research: Neuroimaging by A. Fellgiebel (Author), P.R. Dellani (Author), D. Greverus (Author), Scheuric (Author) This digital document is a journal article from Psychiatry Research: Neuroimaging, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Abstract: In our prospective study of diffusion tensor imaging (DTI), we measured hippocampal mean diffusivity (MD) and volumes in amnestic mild cognitive impairment (MCI). Thirteen MCI patients were followed-up by clinical assessment over a mean 112-year period. MCI patients who converted to dementia (6 of 13) during the observation period had slightly elevated left hippocampal mean diffusivity at baseline compared with MCI patients who remained clinically stable. Hippocampal volumes as well as baseline verbal... |
|
Mild Cognitive Impairment Signals Early Alzheimer's, Not Normal Aging Process.(Brief Article): An article from: Family Practice News by Mary Ann Moon (Author) This digital document is an article from Family Practice News, published by International Medical News Group on September 1, 2000. The length of the article is 2152 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Mild Cognitive Impairment Signals Early Alzheimer's, Not Normal Aging Process.(Brief Article) Author: Mary Ann Moon Publication: Family Practice News (Magazine/Journal) Date: September 1, 2000 Publisher: International Medical News Group Volume: 30 Issue: 17 Page: 18 Article Type: Brief Article Distributed by Thomson... | |
|
Mild cognitive impairment is widespread. (People Over Age 70).: An article from: Clinical Psychiatry News by Miriam E. Tucker (Author) This digital document is an article from Clinical Psychiatry News, published by International Medical News Group on November 1, 2002. The length of the article is 2622 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Mild cognitive impairment is widespread. (People Over Age 70). Author: Miriam E. Tucker Publication: Clinical Psychiatry News (Magazine/Journal) Date: November 1, 2002 Publisher: International Medical News Group Volume: 30 Issue: 11 Page: 45(1) Distributed by Thomson... | |
![Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment [An article from: Brain and Cognition]](http://ecx.images-amazon.com/images/I/51SY68ZAKPL._SL160_.jpg) |
Focused attention deficits in patients with Alzheimer's disease and mild cognitive impairment [An article from: Brain and Cognition] by E.J. Levinoff (Author), D. Saumier (Author), H. Chertkow (Author) This digital document is a journal article from Brain and Cognition, published by Elsevier in 2005. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser. Description: Reaction time (RT) tasks take various forms, and can assess psychomotor speed, (i.e., simple reaction time task), and focused attention (i.e., choice reaction time (CRT) task). If cues are provided before stimulus presentation (i.e., cued choice reaction time (CCRT) task), then a cueing effect can also be assessed. A limited number of studies have addressed the nature of focused attention impairments in Alzheimer's disease (AD). Additionally, it is unknown whether similar impairments occur in Mild Cognitive... |
|
New tests for MCI show potential but have limits.(mild cognitive impairment): An article from: Internal Medicine News by Patrice Wendling (Author) This digital document is an article from Internal Medicine News, published by Thomson Gale on April 1, 2006. The length of the article is 634 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: New tests for MCI show potential but have limits.(mild cognitive impairment) Author: Patrice Wendling Publication: Internal Medicine News (Magazine/Journal) Date: April 1, 2006 Publisher: Thomson Gale Volume: 39 Issue: 7 Page: 26(1) Distributed by Thomson... |
| © 2009 BrightSurf.com |